Bayesian regression for group testing data.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28405965)

Published in Biometrics on April 12, 2017

Authors

Christopher S McMahan1, Joshua M Tebbs2, Timothy E Hanson2, Christopher R Bilder3

Author Affiliations

1: Department of Mathematical Sciences, Clemson University, Clemson, South Carolina 29634, U.S.A.
2: Department of Statistics, University of South Carolina, Columbia, South Carolina 29208, U.S.A.
3: Department of Statistics, University of Nebraska-Lincoln, Lincoln, Nebraska 68583, U.S.A.

Articles cited by this

Performance of the APTIMA Combo 2 assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in female urine and endocervical swab specimens. J Clin Microbiol (2003) 3.50

Comparison of group testing algorithms for case identification in the presence of test error. Biometrics (2007) 2.86

Regression models for disease prevalence with diagnostic tests on pools of serum samples. Biometrics (2000) 2.21

Informative Dorfman screening. Biometrics (2011) 2.13

Regression analysis of group testing samples. Stat Med (2001) 1.64

Hepatitis B virus (HBV) DNA screening of blood donations in minipools with the COBAS AmpliScreen HBV test. Transfusion (2005) 1.26

Group testing regression models with fixed and random effects. Biometrics (2009) 1.24

Identifiability of models for multiple diagnostic testing in the absence of a gold standard. Biometrics (2010) 1.17

Gonorrhea and chlamydia infection among women visiting family planning clinics: racial variation in prevalence and predictors. Perspect Sex Reprod Health (2005) 1.11

Estimating prevalence by group testing using generalized linear models. Stat Med (1992) 1.06

Cost savings and increased efficiency using a stratified specimen pooling strategy for Chlamydia trachomatis and Neisseria gonorrhoeae. Sex Transm Dis (2012) 1.05

Risk factors for genital chlamydial infection. Can J Infect Dis (2002) 1.00

Pooled biological specimens for human biomonitoring of environmental chemicals: opportunities and limitations. J Expo Sci Environ Epidemiol (2013) 0.99

Optimality of group testing in the presence of misclassification. Biometrika (2011) 0.96

Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings. Transfus Med (2007) 0.95

Estimating the prevalence of infections in vector populations using pools of samples. Med Vet Entomol (2012) 0.94

Two-dimensional informative array testing. Biometrics (2011) 0.89

Regression models for group testing data with pool dilution effects. Biostatistics (2012) 0.89

Pooled nucleic acid testing increases the diagnostic yield of acute HIV infections in a high-risk population compared to 3rd and 4th generation HIV enzyme immunoassays. J Clin Virol (2014) 0.88

An improved test of latent-variable model misspecification in structural measurement error models for group testing data. Stat Med (2009) 0.81

Group testing regression model estimation when case identification is a goal. Biom J (2013) 0.79